Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704
Abstract: Allogeneic hematopoietic cell transplantation (allo-HCT) is potentially curative for older adults with hematologic malignancies. Concerns on nonrelapse mortality (NRM) in older adults limit allo-HCT utilization. We executed a prospective, observational study BMT-CTN 1704 (Blood and Marrow...
Saved in:
| Main Authors: | Mohamed L. Sorror, Wael Saber, Brent Logan, Nancy Geller, Anna Bellach, Jianqun Kou, William Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Lori Jarrett, Asmita Mishra, Joseph Uberti, Parastoo B. Dahi, Jennifer N. Saultz, Shannon R. McCurdy, Lawrence E. Morris, Philip H. Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Rebecca Olin, Joseph Maakaron, Ronald Sobecks, Sarah A. Wall, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Andrew S. Artz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Blood Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952925001776 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703
by: Sameem Abedin, et al.
Published: (2025-07-01) -
John TD, Walters MC, Rangarajan HG, et al. Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease. Blood Adv. 2024;8(23):6055-6063.
Published: (2025-05-01) -
Materials for the biography of metropolitan Parthenius of Laodicea (? — 1704)
by: Nadezhda Chesnokova
Published: (2023-12-01) -
1703 and 1704 Georgia-Abkhaz Campaign and the Cost of the Campaign
by: Eyüp Kul
Published: (2023-12-01) -
PERAN DAN STRATEGI LEMBAGA KEUANGAN SYARIAH (STUDI KASUS) BMT SYARIAH ATTAQWA & BMT IKHTIAR
by: Arief Budi Santoso
Published: (2018-07-01)